Trials / Not Yet Recruiting
Not Yet RecruitingNCT07401316
Circulating Tumor DNA in Stage I, II, and III Germ-Cell Tumors
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 130 (estimated)
- Sponsor
- Indiana University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study will evaluate the utility of ctDNA detection in patients with high-risk stage I, stage II, and stage III germ cell tumor disease to develop a tool for post-treatment cancer cell detection.
Detailed description
This is a specimen collection study where patients with high-risk stage I germ cell tumor, clinical stage II germ cell tumor, and clinical stage III germ cell tumor will be evaluated for ctDNA.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Whole blood for ctDNA | Whole blood for ctDNA |
Timeline
- Start date
- 2026-03-01
- Primary completion
- 2032-09-01
- Completion
- 2032-12-01
- First posted
- 2026-02-10
- Last updated
- 2026-03-20
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT07401316. Inclusion in this directory is not an endorsement.